Global Dental Bone Graft and Substitutes Market by Product Type, Material Type, End User and by Geography - Trends and Forecast, 2022 - 2028

Bone grafting is replacement of damaged part of dental structure with the help of grafts such as autografts, allograft or xenograft. Patients with teeth missing need to undergo a dental implant procedure, however, if their jaw bone is thin or soft and is not able to hold the dental implant in its place, then they need to undergo a bone graft procedure. Synthetic substitutes such as Hydroxyapatite (HA) and Tricalcium Phosphate (TCP) are also been used in dental procedures. Various factors for dental deformities include gum disease, traumas, injuries, accidents, and genetic defects. Bone grafts offer various advantages such as preserving the structure and strength of the jaw bone, avoids the possibility of narrow and fragile jaw bone.

Market Dynamics

Bone graft materials are available in varieties such as allografts, xenografts, and synthetic substitutes and can be custom made according to the need of the patient, which makes it convenient for both, the physician and patient driving the growth of the market. Bone grafts are widely available from various sources such as from patients, from another donor, from animal sources, or are synthetically made. Furthermore, advancements in technology has led to development of synthetic graft options with better stability, sterility, and long life. These advancements have reduced surgical times along with post-operative pain and have improved healing time increasing adoption of these substitutes which has impacted the market. Development of biocompatible bone grafts such as B-OstiN and hydroxyapatite allografts and advent of different variants is a factor expected to fuel growth of the global dental bone graft substitutes market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of dental bone graft and substitutes market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global dental bone graft and substitutes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies

Key companies covered as a part of this study include Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., and LifeNet Health, Citagenix

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global dental bone graft and substitutes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the dental bone graft and substitutes market

Detailed Segmentation:

Global Dental Bone Graft and Substitutes Market, By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

Global Dental Bone Graft and Substitutes Market, By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

Global Dental Bone Graft and Substitutes Market, By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

Global Dental Bone Graft and Substitutes Market, By Geography:

North America

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

U.S.

Canada

Europe

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

Brazil

Mexico

Rest of Latin America

Middle East

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type:

Demineralized Bone Matrix (DBM)

Allograft

Xenograft

Synthetic Bone Graft Substitutes

By Material Type:

Collagen

Human Cell Source

Animal Source

Hydroxyapatite (HA)

Tricalcium Phosphate (TCP)

Others

By End User:

Hospitals

Clinics

Ambulatory Surgery Centers

By Country:

Central Africa

South Africa

North Africa

Company Profiles

The Straumann Group*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Geistlich

DENTSPLY International

Zimmer Biomet

Medtronic Plc.

BioHorizons IPH, Inc.

ACE Surgical Supply Company, Inc.

RTI Surgical, Inc.

LifeNet Health

Citagenix

 “*” marked represents similar segmentation in other categories in the respective section.